APA (7th ed.) Citation

Hope, K. A., Berman, A. R., Peterson, R. T., & Chow, C. Y. (2022). An in vivo drug repurposing screen and transcriptional analyses reveals the serotonin pathway and GSK3 as major therapeutic targets for NGLY1 deficiency. PLoS Genetics, 18(6), 1. https://doi.org/10.1371/journal.pgen.1010228

Chicago Style (17th ed.) Citation

Hope, Kevin A., Alexys R. Berman, Randall T. Peterson, and Clement Y. Chow. "An in Vivo Drug Repurposing Screen and Transcriptional Analyses Reveals the Serotonin Pathway and GSK3 as Major Therapeutic Targets for NGLY1 Deficiency." PLoS Genetics 18, no. 6 (2022): 1. https://doi.org/10.1371/journal.pgen.1010228.

MLA (9th ed.) Citation

Hope, Kevin A., et al. "An in Vivo Drug Repurposing Screen and Transcriptional Analyses Reveals the Serotonin Pathway and GSK3 as Major Therapeutic Targets for NGLY1 Deficiency." PLoS Genetics, vol. 18, no. 6, 2022, p. 1, https://doi.org/10.1371/journal.pgen.1010228.